Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine.

Mahvi DM, Burkholder JK, Turner J, Culp J, Malter JS, Sondel PM, Yang NS.

Hum Gene Ther. 1996 Aug 20;7(13):1535-43.

PMID:
8864754
2.
3.

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma.

Mahvi DM, Sondel PM, Yang NS, Albertini MR, Schiller JH, Hank J, Heiner J, Gan J, Swain W, Logrono R.

Hum Gene Ther. 1997 May 1;8(7):875-91.

PMID:
9143914
4.

Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma model.

Turner JG, Tan J, Crucian BE, Sullivan DM, Ballester OF, Dalton WS, Yang NS, Burkholder JK, Yu H.

Hum Gene Ther. 1998 May 20;9(8):1121-30.

PMID:
9625251
5.

Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study.

Mahvi DM, Shi FS, Yang NS, Weber S, Hank J, Albertini M, Schiller J, Schalch H, Larson M, Pharo L, Gan J, Heisey D, Warner T, Sondel PM.

Hum Gene Ther. 2002 Sep 20;13(14):1711-21.

PMID:
12396624
6.

Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.

Stagg J, Wu JH, Bouganim N, Galipeau J.

Cancer Res. 2004 Dec 15;64(24):8795-9.

7.

CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy.

Cheng L, Sun J, Pretlow TG, Culp J, Yang NS.

J Natl Cancer Inst. 1996 May 1;88(9):607-11.

PMID:
8609662
8.

Gene gun application in the generation of effector T cells for adoptive immunotherapy.

Tanigawa K, Yu H, Sun R, Nickoloff BJ, Chang AE.

Cancer Immunol Immunother. 2000 Feb;48(11):635-43.

10.

[Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].

Guo C, Liu QG, Yang W, Yao YM.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Feb;28(2):188-92. Chinese.

11.

Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.

Rakhmilevich AL, Imboden M, Hao Z, Macklin MD, Roberts T, Wright KM, Albertini MR, Yang NS, Sondel PM.

Clin Cancer Res. 2001 Apr;7(4):952-61.

12.

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells.

Yu JS, Burwick JA, Dranoff G, Breakefield XO.

Hum Gene Ther. 1997 Jun 10;8(9):1065-72.

PMID:
9189764
13.

Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs.

Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Yang NS, MacEwen EG.

Cancer Gene Ther. 1999 Jan-Feb;6(1):26-36.

14.

Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues.

Rajagopalan LE, Burkholder JK, Turner J, Culp J, Yang NS, Malter JS.

Blood. 1995 Oct 1;86(7):2551-8.

15.

Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.

Qin H, Chatterjee SK.

Hum Gene Ther. 1996 Oct 1;7(15):1853-60.

PMID:
8894677
16.

Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.

Curiel-Lewandrowski C, Mahnke K, Labeur M, Roters B, Schmidt W, Granstein RD, Luger TA, Schwarz T, Grabbe S.

J Immunol. 1999 Jul 1;163(1):174-83.

17.

Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancer.

Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Keller ET, Yang NS, MacEwen EG.

Hum Gene Ther. 1998 Sep 1;9(13):1851-61.

PMID:
9741424
18.

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.

Herrlinger U, Jacobs A, Quinones A, Woiciechowsky C, Sena-Esteves M, Rainov NG, Fraefel C, Breakefield XO.

Hum Gene Ther. 2000 Jul 1;11(10):1429-38.

PMID:
10910140
19.
20.

Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.

Inoue H, Iga M, Nabeta H, Yokoo T, Suehiro Y, Okano S, Inoue M, Kinoh H, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K.

Cancer Sci. 2008 Nov;99(11):2315-26. doi: 10.1111/j.1349-7006.2008.00964.x. Epub 2008 Oct 18.

Supplemental Content

Support Center